Hikal Share Price

Small Cap | Pharmaceuticals and health care | NSE: HIKAL | BSE: 524735

₹355.20 image0.15 (0.04 %)

Last Updated: 21 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 359.60

High (₹) 361.65

Low (₹) 350.85

Prev. Close (₹) 355.05

Volume 9,312

VWAP (₹) 357.81

ROCE (%) 8.77

Industry P/E 43.99

TTM P/E 58.71

P/B Ratio 3.71

Market Cap (₹) Cr.4,409.85

Dividend Yield (%)0.34

EPS (₹) 5.64

ROE5.86%

Sales Growth (%) -11.79

Profit Growth (%)-11.2

Day Range

361.65361.65

L
H

52 Week Range

260.65464.50

L
H

Historical Returns

Returns (6M)

9.41 %

Returns (1Y)

25.14 %

Returns (3Y)

-5.64 %

Returns (5Y)

170.11 %

Returns (6M)

9.41 %

Returns (1Y)

25.14 %

Returns (3Y)

-5.64 %

Returns (5Y)

170.11 %

SWOT Analysis

  • Book value per share improving over the last 2 years
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Positive ROC (9) indicates upward momentum.
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 49.64

MFI 36.14

ATR 19.52

Commodity Channel Index 26.92

ROC125 9.39

ROC21 2.57

Williams %R -52.01

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current362.69367.57373.49356.77351.89345.97341.09
Week Ago356.10369.95379.90346.15332.30322.35308.50
Month Ago385.51398.23405.91377.83365.11357.43344.71

EMA & SMA
info_icon

355.20

Current Price

EMA & SMApin

Bullish Moving Averages

10

Bearish Moving Averages

10

5 Day 349.72


9 Day 349.80


10 Day 351.65


12 Day 359.56


14 Day 355.33

20 Day 352.82


26 Day 357.93


50 Day 371.68


100 Day 376.07


200 Day 352.80

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
29 Dec, 2022Ashok Vishwanath HiremathAcquisition₹354.369830454761527491681191612,622BSE
29 Dec, 2022Ashok Vishwanath HiremathAcquisition₹359.061527680448493342676944628,540BSE
29 Dec, 2022Ashok Vishwanath HiremathAcquisition₹354.46755,600BSE
26 Dec, 2022Ashok Vishwanath HiremathAcquisition₹354.876215,000BSE
26 Dec, 2022Ashok Vishwanath HiremathAcquisition₹348.53072454906756343625802519,813BSE
26 Dec, 2022Ashok Vishwanath HiremathAcquisition₹351.568302550571679859278803928,425BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
04 Feb, 2025Rs.0.6000 per share(30%)Interim Dividend07 Feb, 202508 Feb, 2025
09 May, 2024Rs.0.6000 per share(30%)Final Dividend (BC dates changed as RD and XD also revised)04 Sept, 202404 Sept, 2024
08 Feb, 2024Rs.0.6000 per share(30%)Interim Dividend20 Feb, 202420 Feb, 2024

Announcements

DateSourceDetail
10 Feb, 2025NSE IndiaHikal Limited has informed the Exchange about Transcript of earnings call held on February 4, 2025.
10 Feb, 2025BSE IndiaSubmission of transcript of earnings call held on February 4, 2025
08 Feb, 2025BSE IndiaIntimation under Regulation 30 of SEBI(LODR) Regulations, 2015 - TDS Communication regarding Interim dividend 2024-25
08 Feb, 2025NSE IndiaHikal Limited has informed the Exchange regarding ''Intimation under Regulation 30 of SEBI Listing Regulations, 2015 Communication sent to shareholders regarding Tax Deduction at Source (TDS) on dividend income''.
08 Feb, 2025BSE IndiaIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
08 Feb, 2025NSE IndiaHikal Limited has informed the Exchange regarding ''Intimation under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015''.
06 Feb, 2025NSE IndiaHIKAL LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 04-Feb-2025 for Dividend
05 Feb, 2025NSE IndiaHikal Limited has informed the Exchange about Copy of Newspaper Publication for unaudited standalone and consolidated financial results for the quarter and period ended December 31, 2024
05 Feb, 2025NSE IndiaSubmission of Integrated Filing (Financial) for the quarter and period ended December 31, 2024
04 Feb, 2025NSE IndiaHikal Limited has informed the Exchange about Link of Recording of the investors group call for the standalone and consolidated financial results for the quarter and period ended December 31, 2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & Interim Dividend--30 Jan, 202504 Feb, 2025
Quarterly Results--06 Nov, 202412 Nov, 2024
Quarterly Results--23 Jul, 202401 Aug, 2024
Audited Results & Final Dividend--07 May, 202409 May, 2024
Quarterly Results & Interim Dividend--05 Feb, 202408 Feb, 2024
Quarterly Results--26 Oct, 202302 Nov, 2023
Quarterly Results--03 Aug, 202308 Aug, 2023
Audited Results & Final Dividend--24 May, 202329 May, 2023
Quarterly Results & Interim Dividend--26 Jan, 202302 Feb, 2023
Quarterly Results--03 Nov, 202209 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Hikal

Hikal is a Public Limited Listed company incorporated on 08/07/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1988PTC048028 and registration number is 048028. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1784.60 Cr. and Equity Capital is Rs. 24.66 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Kalyani Group

Founded

1988

Managing Director

Mr. Sameer Hiremath

NSE Symbol

HIKAL

Hikal Management

NameDesignation
Mr. Jai HiremathExecutive Chairman
Mr. Sameer HiremathManaging Director
Mr. Sarangan SureshWhole Time Director
Ms. Sugandha HiremathNon Executive Director
Mr. Amit KalyaniNon Executive Director
Mrs. Shivani Bhasin SachdevaInd. Non-Executive Director
Mr. Shrikrishna AdivarekarInd. Non-Executive Director
Mr. Ramachandra KaundinyaInd. Non-Executive Director
Mr. Berjis DesaiInd. Non-Executive Director
Mr. Ravi KapoorInd. Non-Executive Director
Mr. Ranjana S SalgaocarInd. Non-Executive Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,643.75 image
₹1,669.30(-1.53%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,757.05 image
₹5,978.30(-3.70%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,475.75 image
₹1,479.70(-0.27%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,327.75 image
₹2,348.45(-0.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,151.80 image
₹1,170.95(-1.64%)
₹1,104.690 - ₹1,420.200

FAQs on Hikal

What is the share price of Hikal?

The share price of Hikal on 21 Feb, 2025 is ₹ 355.20.

What is 52W high and 52W low share price of Hikal?

The highest and lowest 52W share prices of Hikal are ₹ 464.500 and ₹ 260.650

What is the market cap of Hikal?

The market capitalization of Hikal as of 21 Feb, 2025 is ₹ 4,409.85 Crores

What is the P/E ratio of Hikal?

The current P/E ratio of Hikal as of 21 Feb, 2025 is 43.99

What is the PB ratio of Hikal?

The PB ratio of Hikal as of 21 Feb, 2025 is 3.71

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited